ID

27678

Descripción

Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML) - NCT01488344 https://clinicaltrials.gov/ct2/show/NCT01488344 Principal Investigator PD Dr. Utz Krug RATIONALE: Low-dose cytarabine works in a minority of elderly patients with an acute myeloid leukemia unfit for intensive induction therapy by killing of leukemia cells. Addition of BIBF1120 to low-dose cytarabine might enhance the killing of leukemia cells. PURPOSE: This phase I / II trial is studying how safe BIBF1120 can be combined with low-dose cytarabine (phase I) and how well the combination of low-dose cytarabine and BIBF1120 works in elderly patients with acute myeloid leukemia unfit for intensive chemotherapy (phase II). Study Type: Interventional Study Design: Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: A Single-arm, Open Label, Multi-center Phase I/II Trial to Assess the Safety and Efficacy of BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With AML Unfit for an Intensive Induction Therapy

Link

https://clinicaltrials.gov/ct2/show/NCT01488344

Palabras clave

Versiones (1)
  1. 26/11/17 26/11/17 -
Titular de derechos de autor

PD Dr. Utz Krug

Subido en

26 de noviembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With AML NCT01488344

Alemán ( localization.languageCode.DE )

Withdrawal from study

1 formularios  
  1. StudyEvent: ODM
    1. Withdrawal from study
Studienabbruch
Descripción

Studienabbruch

Alias
UMLS CUI-1
C0422727
Vorzeitiger Studienabbruch am
Descripción

Date of withdrawal from study

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0444496
UMLS CUI [1,2]
C0011008
Primärer Grund
Descripción

Reason for study withdrawal

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0392360
AE-Nr.:
Descripción

Adverse event code

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0805701
UMLS CUI [1,3]
C1521902
Rezidiv am:
Descripción

Date of relapse

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0035020
UMLS CUI [1,2]
C0011008
Art des Rezidivs:
Descripción

AML Type of relapse

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0205336
Art des extramedullären Rezidives
Descripción

Extramedullary relapse

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0035020
UMLS CUI [1,3]
C1517060
Andere extramedulläre Rezidivlokalisation
Descripción

Other extramedullary relapse manifestation

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1868812
UMLS CUI [1,2]
C1521902
Tod am:
Descripción

Date of death

Tipo de datos

date

Alias
UMLS CUI [1]
C1148348
Anderer Grund:
Descripción

Other reason for withdrawal

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C3840932
Unterschrift
Descripción

Unterschrift

Alias
UMLS CUI-1
C2346576
Datum
Descripción

Date of investigator signature

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Name
Descripción

Investigator name

Tipo de datos

text

Alias
UMLS CUI [1]
C2826892
Unterschrift
Descripción

Investigator signature

Tipo de datos

text

Alias
UMLS CUI [1]
C2346576
Volver a la parte superior de la página

Similar models

Withdrawal from study

1 formularios
  1. StudyEvent: ODM
    1. Withdrawal from study
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Studienabbruch
C0422727 (UMLS CUI-1)
Date of withdrawal from study
Item
Vorzeitiger Studienabbruch am
date
C0444496 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Primärer Grund
integer
C0422727 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Reason for study withdrawal
Code List
Primärer Grund
CL Item
Unerwünschte(s) Ereignis(se) (1)
CL Item
Erkrankungsprogression (2)
CL Item
primär refraktär nach 6 Therapiezyklen (3)
CL Item
Rezidiv am: (4)
CL Item
Tod am: (5)
CL Item
Einverständnis entzogen (6)
CL Item
Fehlende Compliance (7)
CL Item
Anderer Grund (8)
Adverse event code
Item
AE-Nr.:
text
C0877248 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Date of relapse
Item
Rezidiv am:
date
C0035020 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Art des Rezidivs:
integer
C0023467 (UMLS CUI [1,1])
C0205336 (UMLS CUI [1,2])
AML Type of relapse
Code List
Art des Rezidivs:
CL Item
Knochenmark  (1)
CL Item
extramedullär (2)
Item
Art des extramedullären Rezidives
integer
C0023467 (UMLS CUI [1,1])
C0035020 (UMLS CUI [1,2])
C1517060 (UMLS CUI [1,3])
Extramedullary relapse
Code List
Art des extramedullären Rezidives
CL Item
ZNS (1)
CL Item
andere (2)
Other extramedullary relapse manifestation
Item
Andere extramedulläre Rezidivlokalisation
text
C1868812 (UMLS CUI [1,1])
C1521902 (UMLS CUI [1,2])
Date of death
Item
Tod am:
date
C1148348 (UMLS CUI [1])
Other reason for withdrawal
Item
Anderer Grund:
text
C0422727 (UMLS CUI [1,1])
C3840932 (UMLS CUI [1,2])
Item Group
Unterschrift
C2346576 (UMLS CUI-1)
Date of investigator signature
Item
Datum
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Investigator name
Item
Name
text
C2826892 (UMLS CUI [1])
Investigator signature
Item
Unterschrift
text
C2346576 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial